17 days
Time to First Decision

Drugs and Drug Candidates, Volume 5, Issue 1

2026 March - 13 articles

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
You may sign up for email alerts to receive table of contents of newly released issues.
PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (13)

Select all

Retraction

220 Views

1 Page

RETRACTED: Lokanath et al. Exploring Chalcone Derivatives as a Multifunctional Therapeutic Agent: Investigating Antioxidant Potential, Acetylcholinesterase Inhibition and Computational Insights. Drugs Drug Candidates 2025, 4, 16

Sujatha M. Lokanath,
Manjunatha S. Katagi,
Girish S. Bolakatti,
Johnson Samuel and
Belakatte P. Nandeshwarappa

Drugs Drug Candidates2026, 5(1), 3;https://doi.org/10.3390/ddc5010003

31 December 2025

The journal retracts the article titled “Exploring Chalcone Derivatives as a Multifunctional Therapeutic Agent: Investigating Antioxidant Potential, Acetylcholinesterase Inhibition and Computational Insights” [...]

Full Article

Correction

201 Views

1 Page

Correction: Singh et al. Synergistic Interaction of Glycyrrhizin with Norfloxacin Displays ROS-Induced Bactericidal Activity against Multidrug-Resistant Staphylococcus aureus. Drugs Drug Candidates 2023, 2, 295–310

Vigyasa Singh,
Anirban Pal and
Mahendra P. Darokar

Drugs Drug Candidates2026, 5(1), 2;https://doi.org/10.3390/ddc5010002

22 December 2025

In the publication [...]

Full Article

Article

302 Views

14 Pages

Synthesis, In Vitro Antitumor Activity, and In Silico ADMET Evaluation of β-Lapachone-Based Thiosemicarbazones

Elizabete Silva de Sousa,
Edilane Almeida da Silva,
Délis Galvão Guimarães,
Ingrid Louise Santos de Souza,
Arlan de Assis Gonsalves,
Paulo Michel Pinheiro Ferreira,
Rayran Walter Ramos de Sousa,
Marcília Pinheiro da Costa and
Cleônia Roberta Melo Araújo

Drugs Drug Candidates2026, 5(1), 1;https://doi.org/10.3390/ddc5010001

21 December 2025

Background/Objectives: β-Lapachone and triapine are compounds with recognized antitumor potential—the former is an ortho-naphthoquinone, and the latter a thiosemicarbazone inhibitor of ribonucleotide reductase. This study aimed to synthesi...

Full Article

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

Drugs Drug Candidates - ISSN 2813-2998

Imprint

Download Flyer